Safety and Immunogenicity of a Bivalent SARS-CoV-2 Protein Booster Vaccine, SCTV01C in Adults Previously Vaccinated with Inactivated Vaccine: A Randomized, Double-blind, Placebo-controlled Phase 1/2 Clinical Trial
Publication date: Available online 9 December 2022Source: Journal of InfectionAuthor(s): Suad Hannawi, Linda Safeldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, Jian Li, Yuanxin Chen, Liangzhi Xie